“Selective Safety Data Collection in Clinical Studies of Oncology Drugs for Marketing Approval in the United States”. Journal of Regulatory Science 5, no. 2 (August 8, 2017): 36–44. Accessed September 16, 2024. https://regsci-ojs-tamu.tdl.org/regsci/article/view/67.